06.30.10
ICON Central Laboratories has opened a new lab facility in Tianjin, China, in partnership with Fountain Medical Development Ltd. (FMD). The new facility offers 3000 sq. ft. of lab space and is located 70 miles from Beijing. It will deliver site support services to clinical investigators throughout China, and is intended to provide shorter shipping distances between clinical sites and existing lab testing facilities.
The facility will offer testing services that include chemistry, hematology, coagulation, immunology and other testing services to meet study-specific requirements. The lab received CAP (College of American Pathologists) accreditation in May 2010 and is also NGSP Level I Certified.
Tom O’Leary, president of ICON Central Laboratories, said: “Our alliance with Fountain Medical Development (FMD) and the launch of this new facility underlines our commitment to satisfying our clients’ growing demand for quality central laboratory services in the Asia-Pacific region.”
Dan Zheng, chief executive officer, FMD, said: “Partnering with ICON Central Laboratories gives the FMD team access to the resources, systems and infrastructure of a large international organization involved in the management of both large global trials and localized studies. In return, our local knowledge and experience will be utilized by ICON as they work to provide clients with a faster and more cost efficient service.”
The facility will offer testing services that include chemistry, hematology, coagulation, immunology and other testing services to meet study-specific requirements. The lab received CAP (College of American Pathologists) accreditation in May 2010 and is also NGSP Level I Certified.
Tom O’Leary, president of ICON Central Laboratories, said: “Our alliance with Fountain Medical Development (FMD) and the launch of this new facility underlines our commitment to satisfying our clients’ growing demand for quality central laboratory services in the Asia-Pacific region.”
Dan Zheng, chief executive officer, FMD, said: “Partnering with ICON Central Laboratories gives the FMD team access to the resources, systems and infrastructure of a large international organization involved in the management of both large global trials and localized studies. In return, our local knowledge and experience will be utilized by ICON as they work to provide clients with a faster and more cost efficient service.”